Business
Eli Lilly Reports Strong Third Quarter Performance Exceeding Market Expectations
The pharmaceutical company's revenue surged past estimates driven by continued demand for its weight loss medication Zepbound and diabetes treatment Mounjaro.
Hashtag
#EliLilly
2 stories
Latest News
Business
Eli Lilly's Experimental Amylin-Targeting Drug Shows Promise in Treating Obesity and Type 2 Diabetes
Researchers have identified a promising pathway in the amylin hormone, which is released alongside insulin in the pancreas and helps regulate hunger and fullness.